|16.27||+0.0700||+0.43%||Vol 110.87K||1Y Perf -8.42%|
|Aug 11th, 2022 16:00 DELAYED|
|- -||- -%|
|Target Price||-||Analyst Rating||— — 0.00|
|Potential %||-||Finscreener Ranking||— -|
|Insiders Trans % 3/6/12 mo.||-/-/-100||Value Ranking||— -|
|Insiders Value % 3/6/12 mo.||-/-/-100||Growth Ranking||— -|
|Insiders Shares Cnt. % 3/6/12 mo.||-/-/-100||Income Ranking||— -|
|Price Range Ratio 52W %||48.66||Earnings Rating||—|
|Market Cap||591.67M||Earnings Date||-|
Today's Price Range
|Moving Averages:||Strong Buy|
|Earnings History||Estimate||Reported||Surprise %|
|Earnings Per End||Estimate||Revision %||Trend|
|Next Report Date||-|
|Estimated EPS Next Report||-|
|EPS Growth Next 5 Years %||-|
|Avg. Weekly Volume||52.04K|
|Avg. Monthly Volume||66.52K|
|Avg. Quarterly Volume||82.08K|
Nuveen Dow 30SM Dynamic Overwrite Fund of Beneficial Interest (NYSE: DIAX) stock closed at 16.27 per share at the end of the most recent trading day (a 0.43% change compared to the prior day closing price) with a volume of 110.87K shares and market capitalization of 591.67M. Is a component of indices and it is traded on NYSE exchange. The company belongs in the Asset Management industry, Financial Services sector and employs 0 people. Nuveen Dow 30SM Dynamic Overwrite Fund of Beneficial Interest CEO is Cedric H. Antosiewicz.
The one-year performance of Nuveen Dow 30SM Dynamic Overwrite Fund of Beneficial Interest stock is -8.42%, while year-to-date (YTD) performance is -8.44%. DIAX stock has a five-year performance of -1.87%. Its 52-week range is between 14.63 and 18, which gives DIAX stock a 52-week price range ratio of 48.66%
Nuveen Dow 30SM Dynamic Overwrite Fund of Beneficial Interest currently has a PE ratio of 6.20, a price-to-book (PB) ratio of 0.87, a price-to-sale (PS) ratio of 22.77, a price to cashflow ratio of 16.70, a PEG ratio of 2.32, a ROA of 14.27%, a ROC of -% and a ROE of 14.54%. The company’s profit margin is 99.12%, its EBITDA margin is -%, and its revenue ttm is $25.09 Million , which makes it $0.69 revenue per share.
Of the last four earnings reports from Nuveen Dow 30SM Dynamic Overwrite Fund of Beneficial Interest, there were 0 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $0.00 for the next earnings report. Nuveen Dow 30SM Dynamic Overwrite Fund of Beneficial Interest’s next earnings report date is -.
The consensus rating of Wall Street analysts for Nuveen Dow 30SM Dynamic Overwrite Fund of Beneficial Interest is — (), with a target price of $, which is 0.00% compared to the current price. The earnings rating for Nuveen Dow 30SM Dynamic Overwrite Fund of Beneficial Interest stock is (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
Nuveen Dow 30SM Dynamic Overwrite Fund of Beneficial Interest has a dividend yield of 7.30% with a dividend per share of $1.15 and a payout ratio of 47.00%.
Nuveen Dow 30SM Dynamic Overwrite Fund of Beneficial Interest has a Buy technical analysis rating based on Technical Indicators (ADX : 6.76, ATR14 : 0.24, CCI20 : 298.57, Chaikin Money Flow : 0.06, MACD : 0.15, Money Flow Index : 64.44, ROC : 4.77, RSI : 70.30, STOCH (14,3) : 82.98, STOCH RSI : 1.00, UO : 66.88, Williams %R : -17.02), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of Nuveen Dow 30SM Dynamic Overwrite Fund of Beneficial Interest in the last 12-months were: Gifford R. Zimmerman (Sold 2 000 shares of value $34 388 )
Copyright © 2016-2022 Finscreener.org. All Rights Reserved.
Disclaimer: Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex and Tradegate data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.org, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
This could take some time, please wait.